The U.S. Food and Drug Administration approved on Tuesday the sale of Amgen Inc's osteoporosis drug Prolia to help prevent fractures in post-menopausal women just days after the medicine received ...

Age-related osteoporosis, where the bone structure deteriorates and becomes more vulnerable to fracture, is said to affect more than 200 million people worldwide. Drugs are available to treat or delay ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with osteoporosis preferred 6-month ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved zoledronic acid injection as the first therapy to treat postmenopausal osteoporosis for two ...

In patients on dialysis, the use of an injectable monoclonal antibody for prevention of osteoporosis-related fractures may increase the risk of MACE compared with oral bisphosphonates, observational ...

—Alan Auerbach, Kurt Graves, Martin Muenchbach, Elizabeth Stoner Join Board of Directors— CAMBRIDGE, Mass., May 24, 2011 /PRNewswire/ -- Radius Health, Inc. ("Radius") today announced that the company ...